CLSA

Amer Sports, Inc. Announces Pricing of its Initial Public Offering

Retrieved on: 
Thursday, February 1, 2024
Retail, Sports, Other Retail, Other Sports, Outdoors, Specialty, General Sports, EDGAR, BNP PARIBAS, CICC, Amer Sports, Telephone, Varick Street, Attention, Prospectus, BofA Securities, 2nd Floor, HSBC, Sport, Morgan Stanley, UBS, Broadridge Financial Solutions, Citigroup, CLSA, Goldman Sachs, J. P. Morgan, Evercore, Wells Fargo, Sale, Deutsche Bank, Form, Security (finance)

Amer Sports, Inc. (“Amer Sports”), a global group of iconic sports and outdoor brands, announced today the pricing of its initial public offering of 105,000,000 ordinary shares at a public offering price of $13.00 per share.

Key Points: 
  • Amer Sports, Inc. (“Amer Sports”), a global group of iconic sports and outdoor brands, announced today the pricing of its initial public offering of 105,000,000 ordinary shares at a public offering price of $13.00 per share.
  • In connection with the offering, Amer Sports has granted the underwriters a 30-day option to purchase up to an additional 15,750,000 ordinary shares to cover over-allotments.
  • The closing of the offering is expected to occur on February 5, 2024 subject to the satisfaction of customary closing conditions.
  • Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering.

Amer Sports, Inc. Announces Launch of its Initial Public Offering

Retrieved on: 
Monday, January 22, 2024
Fashion, Footwear, Retail, Sports, Outdoors, General Sports, BNP PARIBAS, 2nd Floor, Evercore, CLSA, Prospectus, Deutsche Bank, Morgan Stanley, Amer Sports, BofA Securities, HSBC, Form, EDGAR, UBS, Sale, Sport, Exchange, Goldman Sachs, Citigroup, Wells Fargo, CICC, J. P. Morgan, Attention, Telephone, Varick Street, Broadridge Financial Solutions, Security (finance)

Amer Sports, Inc. (“Amer Sports”), a global group of iconic sports and outdoor brands, announced today the launch of its initial public offering of 100,000,000 ordinary shares.

Key Points: 
  • Amer Sports, Inc. (“Amer Sports”), a global group of iconic sports and outdoor brands, announced today the launch of its initial public offering of 100,000,000 ordinary shares.
  • The initial public offering price is currently expected to be between $16.00 and $18.00 per share.
  • Amer Sports has been approved to list its ordinary shares on the New York Stock Exchange under the symbol “AS”.
  • Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the proposed offering.

Amer Sports, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering

Retrieved on: 
Thursday, January 4, 2024
Footwear, Fashion, Retail, Sports, Outdoors, Specialty, General Sports, Telephone, UBS, 2nd Floor, BNP Paribas, CICC, Goldman Sachs, Sale, EDGAR, Evercore, Form, HSBC, Attention, Register, BofA Securities, Sport, Wells Fargo, J. P. Morgan, Citigroup, Tiger, Varick Street, Amer Sports, Prospectus, Broadridge Financial Solutions, Deutsche Bank, Morgan Stanley, CLSA, Security (finance)

Amer Sports, Inc. (“Amer Sports”), a global group of iconic sports and outdoor brands, announced today that it has publicly filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares.

Key Points: 
  • Amer Sports, Inc. (“Amer Sports”), a global group of iconic sports and outdoor brands, announced today that it has publicly filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • The proposed offering will be made only by means of a prospectus, which forms a part of the Registration Statement.
  • The Registration Statement relating to the proposed offering has been filed with the SEC but has not yet become effective.

Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer

Retrieved on: 
Wednesday, December 6, 2023
Biotechnology, Pharmaceutical, Oncology, General Health, Health, Infectious Diseases, Health Technology, Genetics, Sale, Temple University, Chemistry, Emperor, Entrepreneurship, Therapy, WIB, Precigen, BIO, DSM-IV codes, Edna Adan University, Biotechnology Innovation Organization, CLSA, CBO, Pharmaceutical industry, Fine chemical, Woman

Empress Therapeutics , a company accelerating small molecule drug generation through novel insights linking genes to chemistry, today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).

Key Points: 
  • Empress Therapeutics , a company accelerating small molecule drug generation through novel insights linking genes to chemistry, today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).
  • With more than 25 years of corporate development and operational experience, Ms. Finnerty-Brooks will work closely with the Empress leadership team and board to drive corporate development, including industry partnerships, academic research collaborations, and operational excellence.
  • “Virginia has repeatedly created and delivered value-generating business opportunities at companies big and small in multiple categories over the course of her career,” said Jason Park, Ph.D., Co-Founder and CEO of Empress.
  • She holds a master’s in business administration from Saint Joseph’s University and a bachelor’s degree from Temple University.

Hong Kong based Web3 and blockchain fintech fund launches with USD100m in first close.

Retrieved on: 
Wednesday, October 4, 2023
Titan, Cosmos, Blockchain, Defense Information Systems Agency, Animoca Brands, NFT, Securities and Futures Commission, Internet, MIT Blackjack Team, Pacific Century Group, Y combinator, Security, Non-fungible token, Trust, State Street, Investment, Terminal 3, CLSA, Consumer, UBS, CMCC, EOS.IO, Cosmos Co-operative Bank Ltd, Cryptocurrency, Infrastructure, Fintech, B1

CMCC Global raised USD100m to launch a new venture capital fund that will empower entrepreneurs in Hong Kong and beyond to build innovative Web3 companies.

Key Points: 
  • CMCC Global raised USD100m to launch a new venture capital fund that will empower entrepreneurs in Hong Kong and beyond to build innovative Web3 companies.
  • HONG KONG, Oct. 4, 2023 /PRNewswire/ - Hong Kong's push towards Blockchain enabled Fintech and Web3 innovation received strong tailwind through a new fund that CMCC Global launched this week.
  • The Titan Fund has reached its fundraising target of USD100m in the first close and is supported by a number of world leading blockchain investors.
  • The Titan Fund is an institutional grade fund with State Street as the fund administrator and EY as the auditor.

QuantaSing Group Limited Announces Pricing of Initial Public Offering

Retrieved on: 
Wednesday, January 25, 2023
CLSA, Broadridge Financial Solutions, Madison Avenue, International Finance Centre (Hong Kong), ADSS, Offering, ADS, Sale, American depositary receipt, China International Capital Corporation, Prospectus, Exercise, Security (finance)

BEIJING, Jan. 25, 2023 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced the pricing of its initial public offering (the “Offering”) of 3,250,000 American Depositary Shares (“ADSs”), each one ADS representing three Class A ordinary shares of the Company with par value of US$0.0001 per share, at a price to the public of US$12.50 per ADS for a total offering size of approximately US40.63 million, assuming the underwriters do not exercise their option to purchase additional ADSs.

Key Points: 
  • BEIJING, Jan. 25, 2023 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (“QuantaSing” or the “Company”), a leading online learning service provider in China, today announced the pricing of its initial public offering (the “Offering”) of 3,250,000 American Depositary Shares (“ADSs”), each one ADS representing three Class A ordinary shares of the Company with par value of US$0.0001 per share, at a price to the public of US$12.50 per ADS for a total offering size of approximately US40.63 million, assuming the underwriters do not exercise their option to purchase additional ADSs.
  • Citigroup Global Markets Inc. and China International Capital Corporation Hong Kong Securities Limited are acting as representatives of the underwriters of the Offering, and US Tiger Securities, Inc., CLSA Limited, and Univest Securities LLC are acting as underwriters for the Offering.
  • The Company's registration statement relating to the offering has been filed with, and declared effective by, the United States Securities and Exchange Commission.
  • The offering is being made only by means of a prospectus forming a part of the effective registration statement.

HungryPanda Hosted the First Ever Global Chinese Food Delivery Industry Trend Summit

Retrieved on: 
Friday, December 9, 2022
Speech, City, Food, International, Gala, Environment, Public affairs, Learning, Partnership, Organic, CLSA, Air pollution, Data analysis, Bell, Multimedia, Social change, Education, The Grand, United Nations Foundation, Organization, Renewable energy, Food delivery, Online shopping

MELBOURNE, Australia, Dec. 8, 2022 /PRNewswire/ -- On December 8, 2022, HungryPanda hosted its first ever Golden Panda Award Gala at The Grand Ballroom- Sofitel Melbourne on Collins.

Key Points: 
  • "We are excited to partner with HungryPanda to further develop sustainable practices in the food delivery industry and promote this new rewarding concept for merchants and riders.
  • Since 2017, HungryPanda has empowered the International Chinese delivery industry through its global expansion, accumulation of operational experience and user behavior data and most importantly, its community involvement and giving.
  • As the largest overseas Asian food delivery platform, HungryPanda is committed to improving the supporting the development of overseas Asian communities.
  • Besides, HungryPanda is awarded in the Deloitte 2021 UK Technology Fast 50, making the company the only food delivery platform in the ranking.

Canada's first and largest-scale vision-loss study is underway at St. Joe's thanks to $750,000 grant from the Juravinski Research Institute

Retrieved on: 
Monday, November 7, 2022
Retina, Anxiety, Eye, Biomarker, AMD, Dementia, Severe cognitive impairment, Depression, Hamilton Health Sciences, Injection, Cataract, Central Ontario, Reading, Nature, Goal, JRI, CLSA, McMaster University, Institute, St. Joseph's Healthcare Hamilton, Risk, Disease, Child, Time, Patient, Social isolation, COVID-19, Prevalence, St. Joe, Health, Macular degeneration, Research, Hope, Pharmaceutical industry, Ageing, Ophthalmology, Saint Joseph's

AMD is the leading cause of vision loss and legal blindness in Canadians aged 55 and older.

Key Points: 
  • AMD is the leading cause of vision loss and legal blindness in Canadians aged 55 and older.
  • study, it will leverage a randomized selection of retinal images and biomarkers from people (age 45-85) enrolled in the Canadian Longitudinal Study on Aging (CLSA) and other cohorts.
  • The research team will examine the images to measure and quantify the progressive disease at various stages over time.
  • The study is being led by Dr. Varun Chaudhary , Chief of Ophthalmology at St. Joe's and a professor of surgery at McMaster University.

Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi

Retrieved on: 
Wednesday, September 28, 2022
DPN, Safety, Ageing, Kidney, HDAC, Industry, Patient, Sickle cell disease, Technology, Uric acid, Metastasis, Peripheral neuropathy, Classification, Brain, Disease, Movement disorders, Lists of diseases, Inflammation, Fibrosis, Food, Leukemia, RNA, Traffic barrier, Circulatory system, HDAC6, Diabetes, Neurodegeneration, ODD, Risk, FDA, BRAF, Cancer, Drug discovery, Genome, Gout, ACR, Therapy, Fabry, Fabry disease, Facet joint arthrosis, Cros, ABM, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, CLSA, Protein, CA, Pharmacokinetics, Listeria monocytogenes non-coding RNA, Pharmaceutical industry, Vaccine, F5

ABM-1310, ABM Therapeutic's proprietary clinical candidate developed as a next-generation BRAF inhibitor, is a highly selective, highly water-soluble, orally administrated, and brain-penetrant small molecule BRAF inhibitor.

Key Points: 
  • ABM-1310, ABM Therapeutic's proprietary clinical candidate developed as a next-generation BRAF inhibitor, is a highly selective, highly water-soluble, orally administrated, and brain-penetrant small molecule BRAF inhibitor.
  • F5 Therapeutics, which invested and incubated by Viva BioInnovator, was recently awarded the first Servier FAST Discovery Award.
  • Winning this award means F5 stood out from 23 applications, indicating the industry's recognition of F5's innovative treatment methods in the field of biomedicine.
  • AceLink Therapeutics, Inc. (AceLink), invested and incubated by Viva BioInnovator, is an innovative biopharmaceutical company developing transformative therapies for genetic diseases.

Yeahka (09923.HK) share price rises 4.45%, Major brokers grant "Buy" rating

Retrieved on: 
Tuesday, September 6, 2022
CICC, CLSA, HK, Solution, Share repurchase, Nomura, Research report, International, Company, News, CSC Financial, GMV, Ecosystem, Growth, Property management, Online shopping

Its share price climbed by about 30% in the past five trading days.

Key Points: 
  • Its share price climbed by about 30% in the past five trading days.
  • For the six months ended 30 June 2022, the Company's revenue was RMB1,642 million, representing a year-over-year increase of 17.07%.
  • On September 5, Yeahka spent HK$4.955 million on the repurchase of 292,000 shares at a repurchase price of HK$16.74-17.08 per share.
  • About YEAHKA LIMITED (Stock Code: 9923.HK)
    Yeahka is a leading payment-based technology platform dedicated to creating value for merchants and consumers.